Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Neuroendocrine Tumors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 5, 2012-06 ,pp. : 526-542

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr3-octreotide versusF-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy

By Virgolini I.   Patri P.   Novotny C.   Traub T.   Leimer M.   Füger B.   Li S.   Angelberger P.   Raderer M.   Wogritsch S.   Kurtaran A.   Kletter K.   Dudczak R.  

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 41-45

Springer Publishing Company

Access to resources Recommend Favorite

Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours

By Aparicio T.   Ducreux M.   Baudin E.   Sabourin J.-C.   De Baere T.   Mitry E.   Schlumberger M.   Rougier P.  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 1014-1019

Elsevier

Access to resources Recommend Favorite

Somatostatin receptor subtype expression in human tumors

By Hofland L.   Lamberts S.  

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 31-36

Springer Publishing Company

Access to resources Recommend Favorite

Somatostatin Receptor Imaging in Small Cell Lung Cancer

By Berenger N.   Moretti J.L.   Boaziz C.   Vigneron N.   Morere J.F.   Breau J.L.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1429-1431

Elsevier

Access to resources Recommend Favorite